DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Hymecromone
Hymecromone
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
Supplementary Information
Coumarin-Piperazine Derivatives As Biologically Active Compounds
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Biological Potentials of Hymecromone-Based Derivatives: a Systematic Review
Marrakesh Agreement Establishing the World Trade Organization
Co-Crystal Structure of Mixed Molecules
Research on Identification of Chemical Status of Surface Water Bodies of the Dniester River Basin
Green One-Pot Synthesis of Coumarin-Hydroxybenzohydrazide Hybrids and Their Antioxidant Potency
Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
Council of Europe Committee of Ministers (Partial
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Future Medical Treatment of PSC
Coumarins and Metabolic Syndrome: Brief Report RESEARCH ARTICLE
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Fluorescent Properties of Hymecromone and Fluorimetric Analysis of Hymecromone in Compound Dantong Capsule
Dostupnost Léčiv Pro Trávicí Trakt a Metabolická Onemocnění: Kouzlo
Top View
General Information
An Efficient, Mild and Metal Free L-Proline Catalyzed Construction Of
Customs Tariff - Schedule Xxi - 1
Australian Statistics on Medicines 2009
Wo 2007/044693 A2
Functional Disorders in the Sphincter of Oddi and Possibly Reflux-Associated Diseases in the Hepato-Biliary-Cholecysto-Pancreat
Mesh Terms for 2002
Pharmacophore PREPARATION and in VITRO ANTICANCER ACTIVITY
(12) United States Patent (10) Patent No.: US 6,407,073 B1 Trkovnik Et Al
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Coumarin's Anti-Quorum Sensing Activity Can Be Enhanced When
Known Bioactives Library: Prestwick 2 Collection
Targeting Quorum Sensing
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Pharmaceutical Appendix to the Tariff Schedule 2
Establishing a Flow Process to Coumarin-8-Carbaldehydes As Important Synthetic Scaffolds
Pharmaceuticals Appendix
Pharmaceutical NIR
Resolution Ap (2000) 1
(12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
4-Methylumbelliferone Treatment and Hyaluronan Inhibition As a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
Schedule Lxxxix - Macao, China